Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 2.9.2025G.L. Pharma GmbH (GLH-2)0666EPazopanib G.L. Pharma 400 mg filmom obalené tablety (tbl flm 30x400 mg (blis.Al/PVC/PE/PVDC))1.9.2025O
 2.9.2025G.L. Pharma GmbH (GLH-2)2700EJansitin Duo 50 mg/1 000 mg filmom obalené tablety (tbl flm 196x50 mg/1 000 mg (blis.PVC/PVDC/Al))1.9.2025O
 2.9.2025G.L. Pharma GmbH (GLH-2)5360DMelkart Duo 50 mg/1000 mg filmom obalené tablety (tbl flm 60x50 mg/1000 mg (blis.Al/OPA/Al/PVC))10.8.2025O
 2.9.2025Fresenius Kabi s.r.o. (FRK-CZ-3)76881Paclitaxel Kabi 6 mg/ml (con inf 1x5 ml/30 mg (liek.inj.skl.))2.9.2025R
 2.9.2025Fresenius Kabi s.r.o. (FRK-CZ-3)2867ELacosamide Fresenius Kabi 10 mg/ml (sol inf 5x20 ml/200 mg (liek.inj.skl.))2.9.2025R
 2.9.2025Fresenius Kabi s.r.o. (FRK-CZ-3)7393DNorepinephrine Kabi 1 mg/ml (con inf 10x10 ml (amp.skl.))2.9.2025O
 2.9.2025Fresenius Kabi Deutschland GmbH (FRK-1)3723DPemetrexed Fresenius Kabi 25 mg/ml infúzny koncentrát (con inf 1x4 ml/100 mg (liek.inj.skl.))2.9.2025O
 1.9.2025Zentiva k.s. (ZNT-3)7372DDuloxetine Zentiva 60 mg tvrdé gastrorezistentné kapsuly (cps end 28x60 mg (blis. PVC/PVDC/Al))30.4.2025Z
 1.9.2025Instituto Grifols, S.A. (GFO)9513DXembify 200 mg/ml roztok na subkutánnu injekciu (sol icu 1x50 ml/10 g (liek.inj.skl.))18.7.2025U
 1.9.2025Instituto Grifols, S.A. (GFO)57420IGANTIBE 200 IU/ml (sol inj 1x5 ml/1000 IU (amp.skl.))28.8.2025U
 1.9.2025Egis Pharmaceuticals PLC (EGI)4483DAssubex 20 mg (tbl flm 28x20 mg (blis.Al/PVC/PE/PVDC))3.9.2025R
 29.8.2025B.Braun Melsungen AG (BME)33979Ringer´s Braun Injection (sol inf 10x1000 ml (PE obal))28.8.2025R
 29.8.2025Fresenius Kabi Deutschland GmbH (FRK-1)1553ESugammadex Fresenius Kabi 100 mg/ml injekčný roztok (sol inj 10x2 ml/200 mg (liek.inj.skl.))4.9.2025O
 28.8.2025Pharmevid s.r.o. (PEV)8657BPemetrexed Pharmevid 500 mg prášok na koncentrát na infúzny roztok (plc ifc 1x500 mg (liek.inj.skl.))1.9.2025R
 28.8.2025Instituto Grifols, S.A. (GFO)9510DXembify 200 mg/ml roztok na subkutánnu injekciu (sol icu 1x5 ml/1 g (liek.inj.skl.))28.8.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)